Laetitia Gerossier

Laetitia Gerossier

Auto-generated profile, based on publicly available information

Laetitia Gerossier

Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2016 in Nature
Verified
Journal Article
Closed access
ADAdrien Decorsière
Adrien Decorsière
HMHenrik Mueller
Henrik Mueller
PBPieter C. van Breugel
Pieter C. van Breugel
FAFabien Abdul
Fabien Abdul
LGLaetitia Gerossier
Laetitia Gerossier
MSMichel Strubin
Michel Strubin

1 November 2015 in Journal of Hepatology
Verified
Journal Article
Closed access
LLLise Lauterbach-Rivière
Lise Lauterbach-Rivière
LGLaetitia Gerossier
Laetitia Gerossier
ADAurélie Ducroux
Aurélie Ducroux
SDSarah Dion
Sarah Dion
QDQiang Deng
Qiang Deng
CNChristine Neuveut
Christine Neuveut

15 August 2018 in Journal of Virology
Verified
Journal Article
Open access
PDF file
FAFabien Abdul
Fabien Abdul
FFFabien Filleton
Fabien Filleton
LGLaetitia Gerossier
Laetitia Gerossier
APAlexia Paturel
Alexia Paturel
JHJanet Hall
Janet Hall
LELucie Etienne
Lucie Etienne
Infection with hepatitis B virus (HBV) led to 887,000 human deaths in 2015. HBV has been coevolving with mammals for millions of years. Recently, the Smc5/6 complex, which has essential housekeeping functions, was identified as a restriction factor of human HBV antagonized by the regulatory HBx protein. Here we address whether the antiviral activity of Smc5/6 is an important evolutionarily conserved function. We found that all six subunits of Smc5/6 have been conserved in primates, with only Smc6 showing signatures of an “evolutionary arms race.” Using evolution-guided functional analyses that included infections of primary human hepatocytes, we demonstrated that HBx proteins from very divergent mammalian HBVs could all efficiently antagonize Smc5/6, independently of the host species and sites under positive selection. These findings show that Smc5/6 antiviral activity against HBV is an important function in mammals. They also raise the intriguing possibility that Smc5/6 may restrict other, yet-unidentified viruses.

16 November 2018 in Cancers
Verified
Journal Article
Open access
PDF file
MAMarie Alexandra Albaret
Marie Alexandra Albaret
CVClaudine Vermot-Desroches
Claudine Vermot-Desroches
APArnaud Paré
Arnaud Paré
JRJean-Xavier Roca-Martinez
Jean-Xavier Roca-Martinez
LMLucie Malet
Lucie Malet
Jean-Jacques DiazJean-Jacques Diaz
Jean-Jacques Diaz
Accumulating evidence supports the remarkable presence at the membrane surface of cancer cells of proteins, which are normally expressed in the intracellular compartment. Although these proteins, referred to as externalized proteins, represent a highly promising source of accessible and druggable targets for cancer therapy, the mechanisms via which they impact cancer biology remain largely unexplored. The aim of this study was to expose an externalized form of cytokeratin 8 (eK8) as a key player of colorectal tumorigenesis and characterize its mode of action. To achieve this, we generated a unique antagonist monoclonal antibody (D-A10 MAb) targeting an eight-amino-acid-long domain of eK8, which enabled us to ascertain the pro-tumoral activity of eK8 in both KRAS-mutant and wild-type colorectal cancers (CRC). We showed that this pro-tumoral activity involves a bidirectional eK8-dependent control of caspase-mediated apoptosis in vivo and of the plasminogen-induced invasion process in cellulo. Furthermore, we demonstrated that eK8 is anchored at the plasma membrane supporting this dual function. We, therefore, identified eK8 as an innovative therapeutic target in CRC and provided a unique MAb targeting eK8 that displays anti-neoplastic activities that could be useful to treat CRC, including those harboring KRAS mutations.

25 May 2016 in médecine/sciences
Verified
Journal Article
Open access
PDF file
LLLise Lauterbach-Rivière
Lise Lauterbach-Rivière
LGLaetitia Gérossier
Laetitia Gérossier
OHOlivier Hantz
Olivier Hantz
CNChristine Neuveut
Christine Neuveut
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé

19 October 2016 in médecine/sciences
Verified
Journal Article
Closed access
PDF file
LGLaetitia Gerossier
Laetitia Gerossier
ADAdrien Decorsière
Adrien Decorsière
FAFabien Abdul
Fabien Abdul
OHOlivier Hantz
Olivier Hantz
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé